LIQUIDIA CORPORATION Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $979.00K, a 8.06% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $945.00K, a 11.97% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $906.00K, a 124.26% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $844.00K, a 142.53% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.85M, a 48.32% increase from fiscal 2024.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.25M, a 82.72% increase from fiscal 2023.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2023 was $683.00K, a 164.73% increase from fiscal 2022.
- LIQUIDIA CORPORATION stock issued during period, value, employee stock purchase plan for fiscal 2022 was $258.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $979.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $1.85M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $945.00K 10-Q · filed 2025-11-03 | |
| 2025-03-31 | $906.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $1.25M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $844.00K 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $404.00K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $683.00K 10-K · filed 2026-03-05 | |
| 2023-09-30 | $348.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $335.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $258.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $230.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $28.00K 10-Q · filed 2023-11-07 | |
| 2020-12-31 | $19.41K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $7.92K 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $11.49K 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |